Stories

Bans and excessive restrictions on safer nicotine products do not eliminate demand — they transfer it to illicit markets. Experiences from countries including Thailand and the Netherlands show how prohibition can fuel organised crime, corruption, counterfeit products and greater risks for consumers. Effective tobacco policy should regulate lower-risk alternatives proportionately rather than leaving cigarettes legal while pushing safer options underground.

The EU’s tobacco consultation is facing criticism for grouping cigarettes, vapes, nicotine pouches and other products together despite major differences in risk. Harm reduction advocates argue that the questionnaire makes meaningful responses difficult and appears designed to support further restrictions. A credible consultation should allow consumers to distinguish between combustible tobacco and lower-risk alternatives. Good regulation begins with questions that reflect evidence, not predetermined conclusions.

Estonia’s experience shows how restrictive nicotine policies can drive consumers towards illicit markets rather than reduce demand. After flavour restrictions and higher taxes, illegal e-liquid trade reportedly expanded, while relaxing some rules helped restore legal sales and tax revenue. As the EU considers tighter regulation, Estonia offers a warning: disproportionate restrictions may weaken both harm reduction and market oversight.

Tobacco policy should reflect the choices smokers actually face. Cigarettes remain widely available, while legal smoke-free alternatives often encounter stricter scrutiny despite their potential to help adults move away from combustion. Effective regulation must protect young people without ignoring adult smokers, illicit markets or differences in relative risk. Public health should be judged by outcomes, not moral panic around nicotine.

A proposal to place nicotine under international drug-control rules would treat vaping and nicotine pouches more like illicit substances than harm-reduction tools. Critics warn that such an approach could drive legal products out of regulated markets, strengthen illicit trade and make cigarettes comparatively easier to access. Nicotine policy should distinguish between dependence and the far greater harms caused by combustion. Extending prohibition models to safer products risks repeating failures already seen elsewhere.

Public records from Massachusetts raise serious concerns about how generational nicotine bans gained local support. Health officials reportedly coordinated witnesses, prepared testimony and targeted low-profile municipal boards while presenting the resulting campaigns as community-led. In some towns, opposition from residents did not alter decisions that appeared to have been made in advance. Public health policy loses legitimacy when consultation becomes a tool for manufacturing consent rather than testing it.

The EU published a survey on future tobacco and nicotine regulation, aiming to shape upcoming policies. The survey raises concerns due to its limited scope and lack of consideration for harm reduction strategies or citizen input. It highlights a bias towards a prohibitionist approach and fails to address the diverse needs of the one hundred million tobacco and nicotine users in the EU. The survey lacks genuine consultation and instead aims to push a preset agenda. Eight major issues with the questionnaire are identified.

Despite the UK's disposable vape ban, a significant number of vapers still use such devices legally. The ban aimed to reduce environmental waste but inadvertently led to challenges for users and manufacturers. Despite efforts to comply with regulations, manufacturers faced criticism. Calls for a deposit on disposable vapes to encourage recycling have been met with pricing concerns. The focus on "loopholes" overlooks the importance of meeting consumer preferences for user-friendly vaping devices, essential for reducing smoking rates effectively and protecting public health. Addressing unintended consequences of vape regulations requires thoughtful market interventions.

Tobacco control fails when ideology is allowed to override evidence. Long-term data from Sweden and other countries show that smoke-free nicotine alternatives can help reduce smoking-related harm, yet these outcomes are still too often ignored. Harm reduction does not replace traditional tobacco control — it strengthens it by offering practical routes away from combustible cigarettes. Public health policy should follow real-world evidence, not institutional resistance.

The FDA’s stricter review requirements for flavoured vapes are adding to the legal and public health debate over how reduced-risk nicotine products should be regulated. While regulators point to youth protection concerns, critics argue that overly demanding approval standards may limit adult smokers’ access to alternatives that help them move away from cigarettes. The case highlights a central tension in nicotine policy: preventing youth uptake without undermining harm reduction for adults. Regulation should be rigorous, but it should also reflect relative risk, consumer behaviour and the public health cost of keeping cigarettes more accessible than safer alternatives.